Weiss Karin, Lachlan Katherine
Genetics Institute Rambam Health Care Center; Ruth and Bruce Rappaport Faculty of Medicine Technion-Israel Institute of Technology Haifa, Israel
Wessex Clinical Genetics Service University Hospital Southampton NHS Trust; Department of Human Genetics and Genomic Medicine Southampton University Southampton, United Kingdom
neurodevelopmental disorder (-NDD) is associated with developmental delay, speech delay, and usually mild-to-moderate intellectual disability. Variability between individuals with -NDD is significant, and a few have normal intelligence. Other manifestations can include brain anomalies, heart defects, and skeletal abnormalities; less common features are hypogonadism in males, hearing impairment, and ophthalmic abnormalities. Most affected individuals have mild nonspecific dysmorphic facial features with or without macrocephaly.
DIAGNOSIS/TESTING: The diagnosis of -NDD is established in a proband with suggestive findings and a heterozygous pathogenic variant in identified by molecular genetic testing.
Developmental delay / intellectual disability, cervical spine instability and risk of spinal cord compression, refractive errors and strabismus, hearing impairment, congenital heart defects, behavioral issues, growth delay, hypogonadism in males, and renal anomalies are managed per standard care. Follow up of the common manifestations at each clinic visit. Activities that involve rapid neck motion and/or possible trauma to the head and neck region (e.g., contact sports or thrill rides at amusement parks) because of the possible increased risk for cervical spine instability and spinal cord compression.
-NDD is an autosomal dominant disorder typically caused by a pathogenic variant. If the pathogenic variant identified in the proband is not identified in either parent, the risk to sibs is low (~1%) but greater than that of the general population because of the possibility of parental germline mosaicism. Once the pathogenic variant has been identified in an affected family member, prenatal and preimplantation genetic testing are possible.
神经发育障碍(-NDD)与发育迟缓、语言迟缓相关,通常伴有轻度至中度智力障碍。患有-NDD的个体之间差异显著,少数个体智力正常。其他表现可能包括脑异常、心脏缺陷和骨骼异常;较少见的特征有男性性腺功能减退、听力障碍和眼部异常。大多数受影响个体有轻度非特异性畸形面部特征,可有或无巨头畸形。
诊断/检测:在先证者中,根据提示性发现以及分子遗传学检测鉴定出的杂合致病变异来确诊-NDD。
发育迟缓/智力障碍、颈椎不稳定和脊髓受压风险、屈光不正和斜视、听力障碍、先天性心脏缺陷、行为问题、生长发育迟缓、男性性腺功能减退和肾脏异常,均按照标准护理进行处理。每次门诊就诊时对常见表现进行随访。由于颈椎不稳定和脊髓受压风险可能增加,避免进行涉及快速颈部运动和/或可能对头颈部区域造成创伤的活动(如接触性运动或游乐园的惊险游乐设施)。
-NDD是一种常染色体显性疾病,通常由一种致病变异引起。如果在先证者中鉴定出的致病变异在父母双方中均未发现,同胞的患病风险较低(约1%),但由于父母生殖腺嵌合体的可能性,其风险高于一般人群。一旦在受影响的家庭成员中鉴定出致病变异,就可以进行产前和植入前基因检测。